0000899243-21-012680.txt : 20210318
0000899243-21-012680.hdr.sgml : 20210318
20210318204837
ACCESSION NUMBER: 0000899243-21-012680
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210126
FILED AS OF DATE: 20210318
DATE AS OF CHANGE: 20210318
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Klickstein Lloyd
CENTRAL INDEX KEY: 0001776004
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38359
FILM NUMBER: 21756202
MAIL ADDRESS:
STREET 1: C/O RESTORBIO, INC.
STREET 2: 500 BOYLSTON STREET, 12TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adicet Bio, Inc.
CENTRAL INDEX KEY: 0001720580
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813305277
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 BOYLSTON STREET
STREET 2: 12TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-482-2333
MAIL ADDRESS:
STREET 1: 500 BOYLSTON STREET
STREET 2: 12TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: resTORbio, Inc.
DATE OF NAME CHANGE: 20171024
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-01-26
1
0001720580
Adicet Bio, Inc.
ACET
0001776004
Klickstein Lloyd
C/O ADICET BIO, INC.
500 BOYLSTON STREET, 13TH FLOOR
BOSTON
MA
02116
0
1
0
0
Chief Innovation Officer
Common Stock
2019-12-06
4
A
0
16888
0.00
D
16888
D
Common Stock
2020-10-23
4
F
0
4957
0.00
D
11931
D
The Reporting Person was issued Restricted Stock Units ("RSU"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest in four (4) annual installments, with the first tranche vesting on December 6, 2020. The RSUs may be settled only by delivering shares of common stock, and thus, the grant is being reported in Table I as allowed per SEC guidance
The amount of securities reported herein have been adjusted to reflect the 1-for-7 reverse stock split that was effected in September 2020 in connection with the merger of resTORbio, Inc. and Adicet Therapeutics, Inc., formerly known as Adicet Bio, Inc.
The Reporting Person is disposing of 4,957 restricted stock units as a result of a revised tax rate for such restricted stock units
/s/ Nick Harvey, Attorney-in-Fact
2021-03-18